Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 27 | 2023 | 715 | 4.080 |
Why?
|
Thoracic Vertebrae | 24 | 2019 | 613 | 3.420 |
Why?
|
Lumbar Vertebrae | 31 | 2024 | 1885 | 3.040 |
Why?
|
Spinal Fusion | 27 | 2024 | 1310 | 2.580 |
Why?
|
Spinal Cord Injuries | 15 | 2019 | 928 | 2.370 |
Why?
|
Neurosurgical Procedures | 29 | 2020 | 2097 | 2.200 |
Why?
|
Laminectomy | 10 | 2019 | 226 | 2.060 |
Why?
|
Spinal Stenosis | 7 | 2024 | 261 | 1.990 |
Why?
|
Cervical Vertebrae | 11 | 2024 | 982 | 1.920 |
Why?
|
Spine | 18 | 2023 | 1142 | 1.910 |
Why?
|
Spondylolisthesis | 9 | 2024 | 173 | 1.870 |
Why?
|
Neurosurgery | 12 | 2019 | 690 | 1.760 |
Why?
|
Spinal Cord Neoplasms | 9 | 2016 | 263 | 1.640 |
Why?
|
Spinal Injuries | 13 | 2021 | 300 | 1.510 |
Why?
|
Spinal Cord Diseases | 6 | 2022 | 293 | 1.470 |
Why?
|
Spinal Cord Compression | 7 | 2019 | 234 | 1.440 |
Why?
|
Spinal Fractures | 13 | 2021 | 712 | 1.330 |
Why?
|
Pneumocephalus | 2 | 2020 | 47 | 1.330 |
Why?
|
Decompression, Surgical | 12 | 2024 | 612 | 1.310 |
Why?
|
Hematoma, Subdural, Chronic | 2 | 2020 | 100 | 1.240 |
Why?
|
Epidural Space | 4 | 2016 | 123 | 1.120 |
Why?
|
Radiculopathy | 4 | 2015 | 203 | 1.100 |
Why?
|
Astrocytoma | 6 | 2018 | 780 | 1.080 |
Why?
|
Facial Injuries | 2 | 2023 | 191 | 0.960 |
Why?
|
Sciatica | 2 | 2017 | 97 | 0.950 |
Why?
|
Neck Pain | 1 | 2024 | 190 | 0.830 |
Why?
|
Dura Mater | 3 | 2018 | 297 | 0.800 |
Why?
|
Nerve Regeneration | 3 | 2013 | 801 | 0.790 |
Why?
|
Gait | 3 | 2016 | 822 | 0.780 |
Why?
|
Meningioma | 4 | 2023 | 1222 | 0.780 |
Why?
|
Spinal Diseases | 8 | 2017 | 563 | 0.780 |
Why?
|
Meningeal Neoplasms | 4 | 2023 | 1251 | 0.760 |
Why?
|
Ependymoma | 4 | 2018 | 324 | 0.750 |
Why?
|
Arachnoid Cysts | 2 | 2018 | 60 | 0.720 |
Why?
|
Lidocaine | 2 | 2014 | 545 | 0.720 |
Why?
|
Peripheral Nerves | 2 | 2015 | 492 | 0.640 |
Why?
|
Spondylosis | 1 | 2019 | 85 | 0.630 |
Why?
|
Epidural Neoplasms | 1 | 2018 | 24 | 0.630 |
Why?
|
Chondrosarcoma | 2 | 2023 | 306 | 0.620 |
Why?
|
Vertebroplasty | 2 | 2011 | 79 | 0.610 |
Why?
|
Craniotomy | 6 | 2020 | 748 | 0.600 |
Why?
|
Surgical Mesh | 1 | 2021 | 316 | 0.590 |
Why?
|
Hemangioma, Cavernous | 1 | 2018 | 107 | 0.570 |
Why?
|
Recovery of Function | 5 | 2015 | 2994 | 0.570 |
Why?
|
Communication Aids for Disabled | 1 | 2017 | 56 | 0.560 |
Why?
|
Anesthetics, Local | 2 | 2014 | 1005 | 0.550 |
Why?
|
Magnetic Resonance Imaging, Interventional | 1 | 2018 | 195 | 0.540 |
Why?
|
Spinal Cord | 5 | 2018 | 1814 | 0.530 |
Why?
|
Manipulation, Spinal | 1 | 2016 | 22 | 0.520 |
Why?
|
Medical Tourism | 1 | 2016 | 52 | 0.510 |
Why?
|
Brain Injuries | 4 | 2013 | 2060 | 0.500 |
Why?
|
Odontoid Process | 2 | 2015 | 46 | 0.490 |
Why?
|
Humans | 147 | 2024 | 768451 | 0.490 |
Why?
|
Glucocorticoids | 2 | 2015 | 2170 | 0.490 |
Why?
|
Stem Cell Transplantation | 4 | 2016 | 1602 | 0.490 |
Why?
|
Bone Substitutes | 1 | 2017 | 233 | 0.490 |
Why?
|
Evidence-Based Medicine | 16 | 2021 | 3708 | 0.480 |
Why?
|
Schwann Cells | 1 | 2015 | 196 | 0.470 |
Why?
|
Methylprednisolone | 2 | 2019 | 387 | 0.470 |
Why?
|
Myelin Proteins | 1 | 2015 | 212 | 0.460 |
Why?
|
Electric Stimulation Therapy | 3 | 2016 | 636 | 0.450 |
Why?
|
Epidural Abscess | 1 | 2015 | 94 | 0.440 |
Why?
|
Locomotion | 3 | 2012 | 391 | 0.430 |
Why?
|
Cryosurgery | 1 | 2018 | 477 | 0.430 |
Why?
|
Lumbosacral Region | 5 | 2021 | 294 | 0.430 |
Why?
|
Pyramidal Tracts | 1 | 2015 | 252 | 0.430 |
Why?
|
Osteotomy | 2 | 2016 | 838 | 0.420 |
Why?
|
Fractures, Spontaneous | 2 | 2019 | 232 | 0.410 |
Why?
|
Neurilemmoma | 1 | 2018 | 524 | 0.410 |
Why?
|
Corynebacterium Infections | 1 | 2011 | 27 | 0.380 |
Why?
|
Simvastatin | 1 | 2014 | 346 | 0.380 |
Why?
|
Insurance, Liability | 1 | 2011 | 100 | 0.370 |
Why?
|
Intracranial Pressure | 1 | 2013 | 325 | 0.360 |
Why?
|
Bone Morphogenetic Protein 2 | 2 | 2014 | 344 | 0.360 |
Why?
|
Cerebral Arteries | 2 | 2012 | 490 | 0.360 |
Why?
|
Decompressive Craniectomy | 1 | 2011 | 76 | 0.350 |
Why?
|
Subdural Space | 2 | 2020 | 38 | 0.350 |
Why?
|
Chondroitin ABC Lyase | 1 | 2010 | 15 | 0.350 |
Why?
|
Spleen | 1 | 2016 | 2298 | 0.350 |
Why?
|
Magnetic Field Therapy | 1 | 2010 | 27 | 0.350 |
Why?
|
Randomized Controlled Trials as Topic | 9 | 2016 | 10358 | 0.350 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2012 | 631 | 0.340 |
Why?
|
Fractures, Compression | 2 | 2011 | 132 | 0.340 |
Why?
|
Off-Label Use | 1 | 2011 | 186 | 0.330 |
Why?
|
Secondary Prevention | 1 | 2016 | 1479 | 0.330 |
Why?
|
Muscle Contraction | 1 | 2014 | 1208 | 0.330 |
Why?
|
Abscess | 2 | 2022 | 607 | 0.330 |
Why?
|
Hemangioblastoma | 3 | 2006 | 62 | 0.330 |
Why?
|
Hemangioma | 3 | 2016 | 727 | 0.320 |
Why?
|
Serotonin Receptor Agonists | 1 | 2009 | 151 | 0.320 |
Why?
|
Low Back Pain | 3 | 2016 | 989 | 0.320 |
Why?
|
Diagnostic Imaging | 3 | 2012 | 3543 | 0.310 |
Why?
|
Paralysis | 1 | 2010 | 250 | 0.310 |
Why?
|
Diphosphonates | 1 | 2013 | 635 | 0.310 |
Why?
|
Vancomycin | 1 | 2012 | 506 | 0.310 |
Why?
|
Treatment Outcome | 30 | 2024 | 65409 | 0.310 |
Why?
|
Mesenchymal Stem Cell Transplantation | 1 | 2013 | 507 | 0.310 |
Why?
|
Pain, Postoperative | 3 | 2019 | 1763 | 0.300 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2010 | 170 | 0.300 |
Why?
|
Postoperative Complications | 10 | 2020 | 15880 | 0.300 |
Why?
|
Hematoma | 1 | 2012 | 768 | 0.290 |
Why?
|
Hindlimb | 1 | 2009 | 516 | 0.290 |
Why?
|
Internal Fixators | 4 | 2021 | 184 | 0.290 |
Why?
|
ADP-Ribosylation Factors | 1 | 2008 | 133 | 0.290 |
Why?
|
Monitoring, Physiologic | 2 | 2013 | 1795 | 0.290 |
Why?
|
Motor Cortex | 1 | 2015 | 1015 | 0.280 |
Why?
|
Nucleic Acids | 1 | 2010 | 190 | 0.280 |
Why?
|
Diskectomy | 2 | 2013 | 208 | 0.280 |
Why?
|
Multicenter Studies as Topic | 4 | 2013 | 1727 | 0.280 |
Why?
|
Malpractice | 1 | 2011 | 561 | 0.270 |
Why?
|
Cerebral Angiography | 1 | 2012 | 1282 | 0.270 |
Why?
|
Conflict of Interest | 1 | 2011 | 556 | 0.270 |
Why?
|
Posterior Cerebral Artery | 1 | 2006 | 35 | 0.270 |
Why?
|
Aged | 41 | 2024 | 171520 | 0.260 |
Why?
|
Bone Density Conservation Agents | 1 | 2013 | 797 | 0.260 |
Why?
|
Neuroprotective Agents | 1 | 2012 | 960 | 0.260 |
Why?
|
Tomography, Optical Coherence | 1 | 2019 | 2958 | 0.260 |
Why?
|
Cerebrospinal Fluid Rhinorrhea | 1 | 2006 | 87 | 0.260 |
Why?
|
Sphenoid Sinus | 1 | 2006 | 101 | 0.260 |
Why?
|
Paraplegia | 2 | 2016 | 161 | 0.260 |
Why?
|
Glioma | 4 | 2016 | 3523 | 0.250 |
Why?
|
Patient Education as Topic | 1 | 2016 | 2339 | 0.250 |
Why?
|
Middle Aged | 43 | 2024 | 223418 | 0.250 |
Why?
|
Male | 53 | 2024 | 364781 | 0.250 |
Why?
|
Female | 58 | 2024 | 396943 | 0.240 |
Why?
|
Motor Activity | 1 | 2014 | 2722 | 0.230 |
Why?
|
Occipital Lobe | 1 | 2006 | 376 | 0.230 |
Why?
|
Sufentanil | 1 | 2024 | 42 | 0.230 |
Why?
|
Neurology | 1 | 2012 | 786 | 0.230 |
Why?
|
Guidelines as Topic | 9 | 2019 | 1395 | 0.220 |
Why?
|
Joint Prosthesis | 1 | 2005 | 251 | 0.220 |
Why?
|
Cranial Fossa, Anterior | 1 | 2003 | 13 | 0.220 |
Why?
|
Brain Neoplasms | 7 | 2016 | 9182 | 0.220 |
Why?
|
Transforming Growth Factor beta | 1 | 2011 | 2003 | 0.220 |
Why?
|
Carotid Artery, Internal | 1 | 2006 | 446 | 0.220 |
Why?
|
Adult | 36 | 2023 | 223542 | 0.220 |
Why?
|
Neuralgia | 1 | 2010 | 620 | 0.210 |
Why?
|
Patient Care Planning | 2 | 2019 | 904 | 0.210 |
Why?
|
Practice Guidelines as Topic | 4 | 2016 | 7451 | 0.210 |
Why?
|
Preoperative Care | 3 | 2020 | 2257 | 0.200 |
Why?
|
Arthrodesis | 3 | 2019 | 186 | 0.200 |
Why?
|
Surgical Wound Infection | 1 | 2012 | 1544 | 0.200 |
Why?
|
Radiation Dosage | 1 | 2011 | 1973 | 0.200 |
Why?
|
Back Pain | 3 | 2022 | 547 | 0.200 |
Why?
|
Streptococcus anginosus | 1 | 2022 | 25 | 0.200 |
Why?
|
Brain Edema | 1 | 2006 | 608 | 0.200 |
Why?
|
PTEN Phosphohydrolase | 1 | 2008 | 1119 | 0.200 |
Why?
|
Arthroplasty, Replacement | 1 | 2005 | 310 | 0.200 |
Why?
|
Disability Evaluation | 2 | 2024 | 1839 | 0.200 |
Why?
|
Vascular Surgical Procedures | 3 | 2008 | 1509 | 0.190 |
Why?
|
Neurofibromatoses | 1 | 2006 | 300 | 0.190 |
Why?
|
Pain Measurement | 4 | 2024 | 3577 | 0.190 |
Why?
|
Rats | 9 | 2016 | 23839 | 0.190 |
Why?
|
Skin | 1 | 2015 | 4520 | 0.190 |
Why?
|
Retrospective Studies | 26 | 2024 | 81834 | 0.190 |
Why?
|
Prognosis | 7 | 2024 | 30028 | 0.180 |
Why?
|
Biopsy | 1 | 2013 | 6816 | 0.180 |
Why?
|
Cerebral Hemorrhage | 1 | 2012 | 2665 | 0.180 |
Why?
|
Occupational Exposure | 1 | 2011 | 1818 | 0.180 |
Why?
|
Hypotension | 1 | 2006 | 888 | 0.180 |
Why?
|
Antigens, Neoplasm | 2 | 2008 | 2003 | 0.180 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 1 | 2019 | 17 | 0.170 |
Why?
|
Computers, Handheld | 1 | 2022 | 211 | 0.170 |
Why?
|
Wounds, Nonpenetrating | 1 | 2006 | 813 | 0.170 |
Why?
|
Frontal Lobe | 1 | 2006 | 1427 | 0.170 |
Why?
|
Orthopedic Procedures | 4 | 2018 | 1280 | 0.170 |
Why?
|
Scoliosis | 1 | 2007 | 793 | 0.170 |
Why?
|
Hydrocephalus | 2 | 2009 | 770 | 0.170 |
Why?
|
Intracranial Aneurysm | 2 | 2006 | 1318 | 0.160 |
Why?
|
Bone Neoplasms | 1 | 2011 | 2562 | 0.160 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3253 | 0.160 |
Why?
|
Animals | 20 | 2016 | 169418 | 0.160 |
Why?
|
Research Design | 2 | 2012 | 6217 | 0.160 |
Why?
|
Cadaver | 2 | 2022 | 1362 | 0.160 |
Why?
|
Subarachnoid Space | 1 | 2018 | 80 | 0.150 |
Why?
|
Prospective Studies | 11 | 2024 | 54914 | 0.150 |
Why?
|
Magnetic Resonance Imaging | 15 | 2024 | 36840 | 0.140 |
Why?
|
Tomography, X-Ray Computed | 9 | 2019 | 20762 | 0.140 |
Why?
|
Walking | 2 | 2019 | 1202 | 0.140 |
Why?
|
Pain | 4 | 2018 | 5096 | 0.140 |
Why?
|
Combined Modality Therapy | 3 | 2023 | 8559 | 0.140 |
Why?
|
Bone Nails | 3 | 2007 | 220 | 0.140 |
Why?
|
Punctures | 1 | 2018 | 372 | 0.140 |
Why?
|
Chordoma | 2 | 2012 | 350 | 0.140 |
Why?
|
Prostheses and Implants | 3 | 2021 | 1279 | 0.140 |
Why?
|
Injections, Spinal | 2 | 2024 | 318 | 0.130 |
Why?
|
Arthroplasty | 3 | 2024 | 310 | 0.130 |
Why?
|
Patient Selection | 4 | 2018 | 4266 | 0.130 |
Why?
|
Genetic Predisposition to Disease | 2 | 2017 | 18048 | 0.130 |
Why?
|
Vision Disorders | 1 | 2003 | 1092 | 0.130 |
Why?
|
Aged, 80 and over | 14 | 2022 | 59680 | 0.130 |
Why?
|
Neurologic Examination | 1 | 2019 | 916 | 0.130 |
Why?
|
Blood Loss, Surgical | 1 | 2019 | 643 | 0.120 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3837 | 0.120 |
Why?
|
Fracture Fixation, Internal | 2 | 2019 | 981 | 0.120 |
Why?
|
Multivariate Analysis | 3 | 2019 | 12096 | 0.120 |
Why?
|
Vascular Neoplasms | 1 | 2016 | 167 | 0.120 |
Why?
|
Osteomyelitis | 1 | 2018 | 408 | 0.120 |
Why?
|
Morphine | 1 | 2018 | 658 | 0.110 |
Why?
|
Biopsy, Needle | 1 | 2019 | 1629 | 0.110 |
Why?
|
Glioblastoma | 2 | 2016 | 3523 | 0.110 |
Why?
|
Neuroendoscopy | 1 | 2015 | 101 | 0.110 |
Why?
|
Therapeutic Irrigation | 1 | 2015 | 297 | 0.110 |
Why?
|
Medulla Oblongata | 1 | 2015 | 248 | 0.110 |
Why?
|
Sulfotransferases | 1 | 2014 | 150 | 0.110 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7471 | 0.110 |
Why?
|
Injections, Epidural | 1 | 2015 | 203 | 0.110 |
Why?
|
Glasgow Coma Scale | 2 | 2021 | 581 | 0.110 |
Why?
|
Geriatric Assessment | 1 | 2020 | 1422 | 0.100 |
Why?
|
Age Distribution | 3 | 2009 | 2881 | 0.100 |
Why?
|
Constriction, Pathologic | 3 | 2022 | 1103 | 0.100 |
Why?
|
Physicians | 1 | 2011 | 4615 | 0.100 |
Why?
|
Body Temperature | 1 | 2016 | 781 | 0.100 |
Why?
|
Aging | 2 | 2009 | 8761 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2014 | 18388 | 0.100 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2012 | 10 | 0.100 |
Why?
|
Young Adult | 11 | 2022 | 60045 | 0.100 |
Why?
|
Thromboembolism | 1 | 2019 | 1006 | 0.100 |
Why?
|
Imaging, Three-Dimensional | 2 | 2024 | 4077 | 0.100 |
Why?
|
Powders | 1 | 2012 | 79 | 0.100 |
Why?
|
Fluoroscopy | 2 | 2018 | 952 | 0.100 |
Why?
|
Giant Cell Tumors | 1 | 2012 | 89 | 0.100 |
Why?
|
Pneumonectomy | 2 | 2016 | 1159 | 0.100 |
Why?
|
Cohort Studies | 7 | 2024 | 41797 | 0.090 |
Why?
|
Analgesics | 1 | 2018 | 1070 | 0.090 |
Why?
|
Logistic Models | 3 | 2019 | 13324 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15460 | 0.090 |
Why?
|
Lung Neoplasms | 4 | 2019 | 13589 | 0.090 |
Why?
|
Angiography, Digital Subtraction | 1 | 2012 | 335 | 0.090 |
Why?
|
Exophthalmos | 1 | 2011 | 100 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 611 | 0.090 |
Why?
|
Observation | 1 | 2012 | 311 | 0.090 |
Why?
|
User-Computer Interface | 1 | 2017 | 1397 | 0.090 |
Why?
|
Joint Instability | 1 | 2018 | 802 | 0.090 |
Why?
|
Medical Illustration | 2 | 2008 | 135 | 0.090 |
Why?
|
Physician-Patient Relations | 1 | 2023 | 3267 | 0.090 |
Why?
|
Radiotherapy | 3 | 2017 | 1510 | 0.090 |
Why?
|
Glial Cell Line-Derived Neurotrophic Factor | 1 | 2010 | 66 | 0.090 |
Why?
|
Mortality | 2 | 2019 | 2917 | 0.080 |
Why?
|
Efferent Pathways | 1 | 2010 | 165 | 0.080 |
Why?
|
Brain | 2 | 2017 | 27438 | 0.080 |
Why?
|
Carcinoma | 2 | 2019 | 2341 | 0.080 |
Why?
|
Pinealoma | 1 | 2009 | 52 | 0.080 |
Why?
|
Weight-Bearing | 2 | 2009 | 533 | 0.080 |
Why?
|
Risk Factors | 7 | 2024 | 74915 | 0.080 |
Why?
|
Motor Neurons | 1 | 2014 | 872 | 0.080 |
Why?
|
Neural Stem Cells | 1 | 2016 | 892 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2533 | 0.080 |
Why?
|
Time | 2 | 2020 | 546 | 0.080 |
Why?
|
Glycosaminoglycans | 1 | 2012 | 611 | 0.080 |
Why?
|
Hemifacial Spasm | 1 | 2008 | 24 | 0.080 |
Why?
|
Delirium | 1 | 2020 | 1694 | 0.080 |
Why?
|
Pineal Gland | 1 | 2009 | 158 | 0.080 |
Why?
|
Databases, Factual | 2 | 2014 | 8081 | 0.080 |
Why?
|
Watchful Waiting | 1 | 2013 | 496 | 0.080 |
Why?
|
Cerebellopontine Angle | 1 | 2008 | 53 | 0.080 |
Why?
|
Infusions, Intravenous | 1 | 2013 | 2228 | 0.080 |
Why?
|
Electromagnetic Fields | 1 | 2010 | 290 | 0.080 |
Why?
|
Blotting, Northern | 2 | 2008 | 1553 | 0.080 |
Why?
|
Reoperation | 2 | 2016 | 4342 | 0.080 |
Why?
|
Hemodynamics | 1 | 2019 | 4202 | 0.080 |
Why?
|
Polyribosomes | 1 | 2008 | 109 | 0.070 |
Why?
|
Bone Morphogenetic Proteins | 2 | 2011 | 848 | 0.070 |
Why?
|
Electromyography | 2 | 2009 | 1399 | 0.070 |
Why?
|
Genomics | 1 | 2023 | 5909 | 0.070 |
Why?
|
Prevalence | 1 | 2024 | 15880 | 0.070 |
Why?
|
Recurrence | 1 | 2020 | 8510 | 0.070 |
Why?
|
Survival Analysis | 5 | 2023 | 10125 | 0.070 |
Why?
|
Cranial Fossa, Middle | 1 | 2006 | 29 | 0.070 |
Why?
|
Ribs | 1 | 2008 | 261 | 0.070 |
Why?
|
Principal Component Analysis | 1 | 2009 | 949 | 0.070 |
Why?
|
Temporal Muscle | 1 | 2006 | 36 | 0.070 |
Why?
|
Gravitation | 1 | 2006 | 82 | 0.070 |
Why?
|
Bone Screws | 2 | 2007 | 534 | 0.070 |
Why?
|
Lipoma | 1 | 2008 | 296 | 0.070 |
Why?
|
Brain Abscess | 1 | 2007 | 123 | 0.070 |
Why?
|
Calcium Channels | 1 | 2010 | 624 | 0.070 |
Why?
|
Pain Threshold | 1 | 2010 | 606 | 0.060 |
Why?
|
Sella Turcica | 1 | 2006 | 117 | 0.060 |
Why?
|
Tissue Transplantation | 1 | 2006 | 128 | 0.060 |
Why?
|
Hyperalgesia | 1 | 2010 | 527 | 0.060 |
Why?
|
Hemangioma, Cavernous, Central Nervous System | 1 | 2006 | 58 | 0.060 |
Why?
|
Hematoma, Subdural, Spinal | 1 | 2005 | 8 | 0.060 |
Why?
|
Sex Distribution | 2 | 2008 | 2286 | 0.060 |
Why?
|
Sphenoid Bone | 1 | 2006 | 177 | 0.060 |
Why?
|
Genes, ras | 1 | 2008 | 666 | 0.060 |
Why?
|
Quality Improvement | 2 | 2020 | 3858 | 0.060 |
Why?
|
Follow-Up Studies | 6 | 2018 | 39430 | 0.060 |
Why?
|
Trauma Severity Indices | 1 | 2006 | 479 | 0.060 |
Why?
|
Algorithms | 1 | 2005 | 14158 | 0.060 |
Why?
|
von Hippel-Lindau Disease | 1 | 2006 | 154 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2012 | 1660 | 0.060 |
Why?
|
Video Recording | 1 | 2009 | 974 | 0.060 |
Why?
|
Stents | 1 | 2016 | 3204 | 0.060 |
Why?
|
Time Factors | 5 | 2016 | 40271 | 0.060 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2008 | 679 | 0.060 |
Why?
|
Reflex Sympathetic Dystrophy | 1 | 2024 | 60 | 0.060 |
Why?
|
Diagnosis, Differential | 2 | 2018 | 13026 | 0.060 |
Why?
|
Cicatrix | 1 | 2010 | 799 | 0.060 |
Why?
|
Reproducibility of Results | 1 | 2022 | 20231 | 0.060 |
Why?
|
Spinal Nerve Roots | 1 | 2023 | 122 | 0.050 |
Why?
|
Cerebellar Neoplasms | 1 | 2008 | 590 | 0.050 |
Why?
|
Oximetry | 1 | 2006 | 462 | 0.050 |
Why?
|
Infusion Pumps, Implantable | 1 | 2024 | 158 | 0.050 |
Why?
|
Spinal Dysraphism | 1 | 2005 | 178 | 0.050 |
Why?
|
Arteriovenous Malformations | 1 | 2006 | 396 | 0.050 |
Why?
|
Review Literature as Topic | 1 | 2005 | 354 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2005 | 344 | 0.050 |
Why?
|
Breast Neoplasms | 4 | 2019 | 21156 | 0.050 |
Why?
|
Arteriovenous Fistula | 1 | 2006 | 321 | 0.050 |
Why?
|
Emergency Treatment | 1 | 2006 | 496 | 0.050 |
Why?
|
Communication | 1 | 2017 | 3910 | 0.050 |
Why?
|
Brain Ischemia | 1 | 2016 | 3038 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3961 | 0.050 |
Why?
|
Cross-Sectional Studies | 1 | 2023 | 26351 | 0.050 |
Why?
|
Zygapophyseal Joint | 1 | 2024 | 128 | 0.050 |
Why?
|
Blotting, Western | 2 | 2008 | 5042 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2011 | 6537 | 0.050 |
Why?
|
Patient Readmission | 1 | 2016 | 3308 | 0.050 |
Why?
|
Endovascular Procedures | 1 | 2016 | 2258 | 0.050 |
Why?
|
Recombinant Proteins | 1 | 2011 | 6527 | 0.050 |
Why?
|
Exercise Test | 1 | 2009 | 2186 | 0.050 |
Why?
|
Length of Stay | 2 | 2020 | 6521 | 0.050 |
Why?
|
Neuronal Plasticity | 1 | 2010 | 1448 | 0.050 |
Why?
|
Risk Assessment | 5 | 2020 | 24311 | 0.050 |
Why?
|
Electroencephalography | 1 | 2017 | 6309 | 0.050 |
Why?
|
Gliosarcoma | 1 | 2001 | 115 | 0.050 |
Why?
|
Patient Discharge | 1 | 2014 | 3471 | 0.050 |
Why?
|
Adolescent | 9 | 2022 | 89168 | 0.050 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3437 | 0.050 |
Why?
|
Sirolimus | 1 | 2008 | 1542 | 0.040 |
Why?
|
Thymidine Kinase | 2 | 2016 | 286 | 0.040 |
Why?
|
Longitudinal Ligaments | 1 | 2019 | 25 | 0.040 |
Why?
|
Acute Disease | 1 | 2010 | 7246 | 0.040 |
Why?
|
Astrocytes | 1 | 2008 | 1354 | 0.040 |
Why?
|
Functional Laterality | 1 | 2006 | 2268 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1596 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 2015 | 3763 | 0.040 |
Why?
|
Intraoperative Complications | 1 | 2006 | 1176 | 0.040 |
Why?
|
Neuroimmunomodulation | 1 | 2001 | 188 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2008 | 2465 | 0.040 |
Why?
|
Agrin | 1 | 1999 | 75 | 0.040 |
Why?
|
Neoplasms | 1 | 2008 | 22386 | 0.040 |
Why?
|
Major Histocompatibility Complex | 1 | 2001 | 877 | 0.040 |
Why?
|
England | 1 | 2020 | 533 | 0.040 |
Why?
|
International Classification of Diseases | 2 | 2014 | 925 | 0.040 |
Why?
|
Intraoperative Period | 1 | 2019 | 513 | 0.040 |
Why?
|
Polymerase Chain Reaction | 1 | 2008 | 6091 | 0.040 |
Why?
|
Prosthesis Design | 1 | 2005 | 2126 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6400 | 0.040 |
Why?
|
Perioperative Period | 1 | 2019 | 252 | 0.040 |
Why?
|
Receptors, Cholinergic | 1 | 1999 | 244 | 0.040 |
Why?
|
Peptides | 1 | 2010 | 4368 | 0.040 |
Why?
|
Xenograft Model Antitumor Assays | 2 | 2016 | 3619 | 0.040 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13708 | 0.040 |
Why?
|
Neoplasm Invasiveness | 2 | 2016 | 3637 | 0.040 |
Why?
|
Lymphocyte Count | 1 | 2019 | 793 | 0.040 |
Why?
|
Flucytosine | 1 | 2016 | 33 | 0.030 |
Why?
|
Platelet Count | 1 | 2019 | 786 | 0.030 |
Why?
|
Calcium | 1 | 2010 | 5793 | 0.030 |
Why?
|
Anticoagulants | 2 | 2019 | 4840 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2007 | 5308 | 0.030 |
Why?
|
Cytosine Deaminase | 1 | 2016 | 66 | 0.030 |
Why?
|
Radiography | 2 | 2008 | 6995 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2000 | 1891 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2016 | 17149 | 0.030 |
Why?
|
HSP27 Heat-Shock Proteins | 1 | 2016 | 67 | 0.030 |
Why?
|
Enterobiasis | 1 | 1995 | 1 | 0.030 |
Why?
|
Ganciclovir | 1 | 2016 | 256 | 0.030 |
Why?
|
Frail Elderly | 1 | 2020 | 774 | 0.030 |
Why?
|
Analgesia, Epidural | 1 | 2018 | 332 | 0.030 |
Why?
|
Bupivacaine | 1 | 2018 | 412 | 0.030 |
Why?
|
RNA, Messenger | 1 | 2010 | 12813 | 0.030 |
Why?
|
Bone Transplantation | 2 | 2013 | 925 | 0.030 |
Why?
|
Postoperative Period | 1 | 2019 | 1833 | 0.030 |
Why?
|
Menarche | 1 | 1997 | 538 | 0.030 |
Why?
|
Enterocolitis | 1 | 1995 | 106 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2008 | 7599 | 0.030 |
Why?
|
Braces | 1 | 2014 | 139 | 0.030 |
Why?
|
Treatment Failure | 1 | 2019 | 2656 | 0.030 |
Why?
|
Risk | 1 | 2005 | 9642 | 0.030 |
Why?
|
Child | 4 | 2022 | 80863 | 0.030 |
Why?
|
Comorbidity | 1 | 2008 | 10601 | 0.030 |
Why?
|
Quality of Life | 2 | 2019 | 13497 | 0.030 |
Why?
|
United States | 5 | 2020 | 73121 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9425 | 0.030 |
Why?
|
Heat-Shock Proteins | 1 | 2016 | 798 | 0.020 |
Why?
|
Infant | 2 | 2022 | 36497 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2020 | 2358 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2008 | 8635 | 0.020 |
Why?
|
Fluorouracil | 1 | 2016 | 1656 | 0.020 |
Why?
|
Child, Preschool | 2 | 2022 | 42623 | 0.020 |
Why?
|
Nose | 1 | 2015 | 524 | 0.020 |
Why?
|
Medicare Part A | 1 | 2011 | 40 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2018 | 2925 | 0.020 |
Why?
|
Eosinophilia | 1 | 1995 | 558 | 0.020 |
Why?
|
Genetic Engineering | 1 | 2016 | 936 | 0.020 |
Why?
|
Lymphoma | 1 | 2019 | 1907 | 0.020 |
Why?
|
Rats, Inbred F344 | 2 | 2001 | 826 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2016 | 1107 | 0.020 |
Why?
|
Vestibulocochlear Nerve | 1 | 2008 | 115 | 0.020 |
Why?
|
Ventriculostomy | 1 | 2009 | 132 | 0.020 |
Why?
|
Neoplasm Metastasis | 1 | 2019 | 4931 | 0.020 |
Why?
|
Diplopia | 1 | 2009 | 217 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2016 | 1357 | 0.020 |
Why?
|
Incidence | 2 | 2020 | 21552 | 0.020 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 245 | 0.020 |
Why?
|
Hospital Charges | 1 | 2009 | 351 | 0.020 |
Why?
|
Evoked Potentials, Auditory, Brain Stem | 1 | 2008 | 255 | 0.020 |
Why?
|
Mice | 1 | 2014 | 82045 | 0.020 |
Why?
|
Insurance Claim Review | 1 | 2011 | 745 | 0.020 |
Why?
|
Orthopedic Fixation Devices | 1 | 2007 | 77 | 0.020 |
Why?
|
Orthotic Devices | 1 | 2007 | 131 | 0.020 |
Why?
|
Health Status | 1 | 2019 | 4096 | 0.020 |
Why?
|
Facial Nerve | 1 | 2008 | 277 | 0.020 |
Why?
|
Sacrum | 1 | 2008 | 276 | 0.020 |
Why?
|
Rotavirus | 1 | 1987 | 110 | 0.020 |
Why?
|
Survival Rate | 2 | 2011 | 12875 | 0.020 |
Why?
|
Genes, Neurofibromatosis 2 | 1 | 2005 | 122 | 0.010 |
Why?
|
Immunotherapy | 1 | 2000 | 4728 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2018 | 12450 | 0.010 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2005 | 277 | 0.010 |
Why?
|
Chromosomes, Human, Pair 22 | 1 | 2005 | 348 | 0.010 |
Why?
|
Liver Neoplasms | 1 | 2019 | 4362 | 0.010 |
Why?
|
Pregnancy | 1 | 2005 | 30179 | 0.010 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2005 | 419 | 0.010 |
Why?
|
Mutation | 1 | 2008 | 30243 | 0.010 |
Why?
|
Drug Utilization | 1 | 2009 | 1192 | 0.010 |
Why?
|
Inpatients | 1 | 2014 | 2561 | 0.010 |
Why?
|
California | 1 | 2007 | 1444 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18478 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2022 | 26395 | 0.010 |
Why?
|
Transfection | 2 | 2001 | 5767 | 0.010 |
Why?
|
Cytomegalovirus | 1 | 1987 | 755 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2008 | 2863 | 0.010 |
Why?
|
Blood Vessels | 1 | 2008 | 1112 | 0.010 |
Why?
|
Monitoring, Intraoperative | 1 | 2008 | 952 | 0.010 |
Why?
|
Antigenic Modulation | 1 | 2001 | 11 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2019 | 9066 | 0.010 |
Why?
|
Multiple Myeloma | 1 | 2019 | 5192 | 0.010 |
Why?
|
Medical Records | 1 | 2007 | 1413 | 0.010 |
Why?
|
Hearing Loss | 1 | 2008 | 786 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2016 | 11249 | 0.010 |
Why?
|
Topotecan | 1 | 2000 | 131 | 0.010 |
Why?
|
Registries | 1 | 2016 | 8373 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9526 | 0.010 |
Why?
|
Chromatography, Agarose | 1 | 1999 | 29 | 0.010 |
Why?
|
Receptor Aggregation | 1 | 1999 | 72 | 0.010 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1179 | 0.010 |
Why?
|
Microsurgery | 1 | 2005 | 803 | 0.010 |
Why?
|
Linear Models | 1 | 2009 | 5880 | 0.010 |
Why?
|
Staphylococcus aureus | 1 | 2007 | 1461 | 0.010 |
Why?
|
Range of Motion, Articular | 1 | 2005 | 1599 | 0.010 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 5532 | 0.010 |
Why?
|
Basement Membrane | 1 | 1999 | 349 | 0.010 |
Why?
|
Staphylococcal Infections | 1 | 2007 | 1412 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2008 | 1435 | 0.010 |
Why?
|
Simplexvirus | 1 | 2001 | 805 | 0.010 |
Why?
|
Epidemiologic Factors | 1 | 1997 | 36 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1136 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 1615 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2011 | 12561 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2005 | 4834 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2000 | 2017 | 0.010 |
Why?
|
Gene Transfer Techniques | 1 | 2001 | 1209 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2005 | 4120 | 0.010 |
Why?
|
Enterobius | 1 | 1995 | 1 | 0.010 |
Why?
|
Antibody Formation | 1 | 2000 | 1393 | 0.010 |
Why?
|
Taiwan | 1 | 1997 | 528 | 0.010 |
Why?
|
Oligonucleotide Probes | 1 | 1995 | 417 | 0.010 |
Why?
|
Anthelmintics | 1 | 1995 | 83 | 0.010 |
Why?
|
Extracellular Matrix Proteins | 1 | 1999 | 835 | 0.010 |
Why?
|
DNA Primers | 1 | 1999 | 2826 | 0.010 |
Why?
|
Immunity, Cellular | 1 | 2000 | 1561 | 0.010 |
Why?
|
Larva | 1 | 1995 | 514 | 0.010 |
Why?
|
Cell Division | 1 | 2000 | 4479 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2000 | 6135 | 0.010 |
Why?
|
Up-Regulation | 1 | 2001 | 4138 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 1999 | 3790 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1999 | 3816 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2001 | 3417 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2001 | 5904 | 0.010 |
Why?
|
Age of Onset | 1 | 1997 | 3342 | 0.010 |
Why?
|
Models, Genetic | 1 | 1999 | 3442 | 0.000 |
Why?
|
Gene Expression | 1 | 2001 | 7605 | 0.000 |
Why?
|
Diarrhea | 1 | 1995 | 1320 | 0.000 |
Why?
|
Colloids | 1 | 1987 | 127 | 0.000 |
Why?
|
Dose-Response Relationship, Drug | 1 | 1999 | 10784 | 0.000 |
Why?
|
Immunologic Techniques | 1 | 1987 | 213 | 0.000 |
Why?
|
Odds Ratio | 1 | 1997 | 9687 | 0.000 |
Why?
|
Base Sequence | 1 | 1995 | 12428 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2005 | 11515 | 0.000 |
Why?
|
Microscopy, Electron | 1 | 1987 | 2565 | 0.000 |
Why?
|
Cells, Cultured | 1 | 1999 | 19041 | 0.000 |
Why?
|
Gold | 1 | 1987 | 489 | 0.000 |
Why?
|
Models, Biological | 1 | 1999 | 9505 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1995 | 17647 | 0.000 |
Why?
|